Stephen J. Kanes
2019
In 2019, Stephen J. Kanes earned a total compensation of $4M as Chief Medical Officer at Sage Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $121,580 |
|---|---|
| Option Awards | $1,891,777 |
| Salary | $457,067 |
| Stock Awards | $1,497,485 |
| Other | $2,024 |
| Total | $3,969,933 |
Kanes received $1.9M in option awards, accounting for 48% of the total pay in 2019.
Kanes also received $121.6K in non-equity incentive plan, $457.1K in salary, $1.5M in stock awards and $2K in other compensation.
Rankings
In 2019, Stephen J. Kanes' compensation ranked 3,013th out of 13,971 executives tracked by ExecPay. In other words, Kanes earned more than 78.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,013 out of 13,971 | 78th |
Division Manufacturing | 1,089 out of 5,701 | 81st |
Major group Chemicals And Allied Products | 361 out of 2,200 | 84th |
Industry group Drugs | 295 out of 1,886 | 84th |
Industry Pharmaceutical Preparations | 217 out of 1,398 | 85th |
Pay ratio
| Stephen J. Kanes' Pay | $3,969,933 |
|---|---|
| Median Employee's Pay | $369,650 |
| Pay Ratio | 11to 1 |
In 2019, the annual total compensation of Stephen J. Kanes was $3,969,933.
The annual total compensation of the median employee at Sage Therapeutics was $369,650.
The ratio of Stephen J. Kanes' pay to the pay of median employee was therefore 11 to one.
Source: SEC filing on April 29, 2020.
Kanes' colleagues
We found five more compensation records of executives who worked with Stephen J. Kanes at Sage Therapeutics in 2019.